US Patent Issued to Conagen on June 30 for "Biosynthetic production of variant steviol glycosides" (American, Chinese Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,826, issued on June 30, was assigned to Conagen Inc. (Bedford, Mass.).

"Biosynthetic production of variant steviol glycosides" was invented by Guohong Mao (Burlington, Mass.), Michael Batten (Westford, Mass.), Yang Luo (Wuxi Jiangsu, China) and Oliver Yu (Lexington, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to novel steviol glycosides R6-1, R6-2A, R6-2B, R6-4A, R6-4B and R7-2 and the production of these novel steviol glycosides, such as through enzymatic bioconversion. The use of these novel steviol glycosides as sweeteners and in orally consumable products are also provided."

The patent was filed on June 11...